Market Overview
The global Peripheral Vascular Device Market Market is witnessing significant expansion, driven by the increasing prevalence of peripheral artery disease (PAD), rising geriatric population, and growing demand for minimally invasive vascular procedures. Peripheral vascular devices are medical tools used to diagnose and treat conditions affecting blood vessels outside the heart and brain, particularly in the arms, legs, and abdomen.
The global Peripheral Vascular Device Market was valued at USD 11.26 billion in 2025. It is projected to increase from USD 11.90 billion in 2026 to USD 18.56 billion by 2034, registering a CAGR of 5.7% during the forecast period (2026–2034). The market growth is driven by the rising prevalence of peripheral arterial disease (PAD) and other vascular disorders, along with an expanding geriatric population.
Market Scope
The scope of the Peripheral Vascular Device Market is broad and spans multiple clinical applications, device categories, and end-user segments.
- Peripheral Artery Disease Treatment Applications: Devices are widely used for managing PAD, critical limb ischemia, and chronic venous insufficiency through angioplasty and stenting procedures.
- Minimally Invasive Endovascular Procedures: Increasing adoption of catheter-based interventions is expanding the use of balloons, guidewires, and stents for safer and faster recovery treatments.
- Hospitals and Ambulatory Surgical Centers: These healthcare settings are primary end users, utilizing peripheral vascular devices for both emergency and elective vascular interventions.
- Technological Innovation in Device Design: The market includes drug-eluting stents, bioresorbable scaffolds, atherectomy devices, and advanced imaging-compatible systems designed for improved clinical precision.
This wide scope reflects the growing integration of vascular interventions into mainstream cardiovascular care pathways.
Market Opportunities
The Peripheral Vascular Device Market offers substantial growth opportunities driven by technological innovation, demographic changes, and evolving healthcare delivery models.
- Rising Prevalence of Peripheral Vascular Diseases: Increasing cases of PAD and venous disorders, especially among the aging population and diabetic patients, are creating sustained demand for vascular intervention devices.
- Advancements in Drug-Coated and Bioabsorbable Technologies: Innovations such as drug-eluting balloons and bioresorbable stents are improving long-term outcomes and reducing restenosis risks, opening new commercial opportunities.
- Expansion of Ambulatory Surgical Centers (ASCs): The shift toward outpatient vascular procedures is increasing the adoption of minimally invasive devices in cost-efficient healthcare settings.
- Growing Adoption of Image-Guided Interventions: The integration of advanced imaging technologies such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT) is enhancing procedural accuracy and expanding device utilization.
These opportunities are encouraging manufacturers to invest in research and development to create safer, more effective, and patient-friendly vascular solutions.
Regional Analysis
North America
North America dominates the Peripheral Vascular Device Market due to advanced healthcare infrastructure, high awareness of vascular diseases, and strong adoption of minimally invasive procedures. The region also benefits from favorable reimbursement policies and rapid adoption of advanced medical technologies.
Europe
Europe holds a significant market share driven by a growing elderly population, increasing prevalence of cardiovascular diseases, and strong healthcare systems. The region’s emphasis on early diagnosis and preventive care further supports market growth.
Asia-Pacific
Asia-Pacific is expected to witness the fastest growth during the forecast period. Rising healthcare expenditure, increasing prevalence of diabetes and hypertension, and improving access to advanced medical technologies are key growth drivers. Countries such as China, India, and Japan are experiencing rapid expansion in cardiovascular treatment infrastructure.
Latin America
Latin America is emerging as a growing market due to improving healthcare access, increasing awareness of vascular diseases, and rising investments in hospital infrastructure. Economic development in urban regions is further supporting market adoption.
Middle East & Africa
The Middle East and Africa region is witnessing steady growth, driven by healthcare modernization initiatives, rising burden of chronic diseases, and increasing investments in specialized cardiovascular care facilities.
Browse Full Insights:
https://www.polarismarketresearch.com/industry-analysis/global-peripheral-vascular-device-market
Key Companies
- Abbott Laboratories
- BD
- Becton
- C.R.Bard
- Cook Group
- Cordis Corporation
- Covidien
- Edward Lifesciences Corporation
- Medtronic
- St. Jude Medical
- Teleflex Medical
- Volcano Corporation
Conclusion
The global Peripheral Vascular Device Market is experiencing strong growth momentum, driven by the rising prevalence of peripheral vascular diseases, increasing adoption of minimally invasive procedures, and continuous technological advancements in vascular intervention devices. The growing aging population and increasing incidence of lifestyle-related disorders further amplify market demand.
Despite challenges such as high procedural costs, stringent regulatory approvals, and procedural complexity, ongoing innovation in device design and expanding healthcare infrastructure are expected to support sustained market expansion.
As healthcare systems worldwide continue to prioritize early diagnosis and minimally invasive treatment approaches, peripheral vascular devices will play a crucial role in improving patient outcomes and reducing the global burden of vascular diseases.
More Trending Latest Reports By Polaris Market Research:
Subcutaneous Immunoglobulin Market
Remote Surgery Technology Platforms Market
NUT Midline Carcinoma Treatment Market
Covid-19 Sample Collection Kits Market